Arkolith/Insider Trading/SRPT/Form 4

Nicaise Claude

DirectorSarepta Therapeutics, Inc. (SRPT) · full profile →Form 4 · filed Mar 13, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$248K
Net Open-Market Flow
-$248K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 12, 2025Sell(S)2K$99.64$248K28K
Mar 12, 2025Option exercise(M)10K$25.18$245K30K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 12, 2025Option exercise(M)10K—$00

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-039037) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML